Paul Issaias
General Manager at P.S.Issaias & Associates Int.
Articles
- Pharma needs reps that are less "sales" and "business" oriented
There were few surprises in the results of recent research carried out by Verispan, Pricewaterhouse Coopers and Deloitte Touche.
(Jun 25, 2009) - Member for
- 2 years 32 weeks
History
Most Popular This Month
Featured Articles
-
Pharma and the evolving role of MSLs
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
-
Pharma and cloud computing
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
-
Pharma and KOLs: How to create transparent, collaborative relationships
Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
Latest Podcasts
"Speed and Usability are Key" - insights from Boehringer Ingelheim
An interview with Serkan Erkovan of Boehringer Ingelheim.
Podcast: "Build KOL trust" - insights from Pediapharm
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Podcast: "KOL engagement strategy at Philips Healthcare"
Kevin Appareti, Global Director Medical Science Liaison at Philips Healthcare, gives a short but useful interview on his company's approach to KOL engagement
Upcoming Events
View All Events-
Feb 8, 2012London, UK
-
Feb 14, 2012 - Feb 15, 2012Boston, USA
-
Feb 21, 2012 - Feb 22, 2012Berlin, Germany
-
Feb 21, 2012 - Feb 22, 2012Istanbul, Turkey
-
Mar 27, 2012 - Mar 29, 2012Barcelona
-
Mar 27, 2012 - Mar 29, 2012Barcelona, Spain
-
Mar 28, 2012 - Mar 29, 2012Mexico City, Mexico
-
Apr 11, 2012 - Apr 12, 2012USA
-
May 8, 2012 - May 9, 2012Zurich, Switzerland
-
May 15, 2012 - May 16, 2012Sao Paulo, Brazil
-
May 24, 2012 - May 25, 2012Toronto, Canada
-
May 29, 2012 - May 30, 2012London, UK
-
June 2012Toronto, Canada
-
June 2012USA
-
June 2012Miami, USA